Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
24
Películas cinematográficas
16
Música popular
13
Novela estadounidense
12
Jazz
10
Música para órgano
7
Crítica e interpretación
6
Música rock
6
Correspondencia
5
Comedy films
4
Condiciones sociales
4
Diarios íntimos
4
Estados Unidos
4
Música
4
Música vocal (Jazz)
4
Novelistas ingleses
4
Arte
3
Aspectos sociales
3
Bailarines
3
Blues (Música)
3
Christmas music
3
Foreign films
3
Historia y crítica
3
Libros falsos
3
Literatura estadounidense
3
Motetes
3
Música de jazz
3
Operas
3
Songs (High voice) with piano
3
Songs (Medium voice) with piano
3
-
5161por Metibemu, Damilohun Samuel, Akinloye, Oluseyi Adeboye, Omotuyi, Idowu Olaposi, Okoye, Jude Ogechukwu, Popoola, Mustapha Ayodele, Akamo, Adio Jamiu“…Human epidermal growth factor 2 (HER2) is overexpressed in about 20% of breast cancer and is associated with a poor prognosis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5162por Geist, C., Everett, B. G., Simmons, R. G., Sanders, J. N., Gawron, L. M., Myers, K., Turok, D. K.“…STUDY DESIGN: New start contraceptive clients, who desired to prevent pregnancy for at least one year enrolled in the survey arm of the HER Salt Lake Contraceptive Initiative (September 2015 –March 2017) and responded to the question “What are your future pregnancy plans?” …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5163por Rychłowska-Pruszyńska, Magdalena, Gajewska, Joanna, Ambroszkiewicz, Jadwiga, Karwacki, Marek, Szamotulska, Katarzyna“…The levels of BALP and ECD/HER-2 were measured using immunoenzymatic methods. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5164“…The effect of Hsp90 knockdown on HER2/PI3K/AKT pathway and PD-L1 expression was characterized using qRT-PCR and Western blot analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5165por Wu, Ailin, Zhu, Yanfeng, Han, Bin, Peng, Jiayuan, Deng, Xiaomin, Chen, Wei, Du, Jingchang, Ou, Yu, Peng, Xiaoli, Yu, Xiaoping“…Delphinidin is an anthocyanidin monomer, commonly found in vegetables and fruits, and has demonstrated antitumor effects in the HER-2-positive MDA-MB-453 breast cancer cell line, with low cytotoxicity on normal breast cells. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5166por Fukada, Ippei, Ito, Yoshinori, Kondo, Naoto, Ohtani, Shoichiro, Hattori, Masaya, Tokunaga, Eriko, Matsunami, Nobuki, Mashino, Kohjiro, Kosaka, Taijiro, Tanabe, Masahiko, Yotsumoto, Daisuke, Yamanouchi, Kosho, Sawaki, Masataka, Kashiwaba, Masahiro, Kawabata, Hidetaka, Kuroi, Katsumasa, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu, Masuda, Norikazu“…Eligible patients were women aged 20 years or older, with histologically confirmed invasive breast cancer, clinical Stage IIIA (T2–3 and N2 only), Stage IIIB, and Stage IIIC, HER2-negative. RESULTS: A preplanned interim analysis aimed to validate the trial assumptions was conducted after treatment of 20 patients and demonstrated that clinical progressive disease rates in the E phase were significantly higher (30%) than assumed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5167por Guo, Lin‐Wei, Li, Xiao‐Guang, Yang, Yun‐Song, Lu, Xun‐Xi, Han, Xiang‐Chen, Lang, Guan‐Tian, Chen, Li, Shao, Zhi‐Ming, Hu, Xin“…BACKGROUND: Few studies have discussed the contradictory roles of mutated‐PI3Kα in HER2‐positive (HER2+) breast cancer. Thus, we characterised the adaptive roles of PI3Kα mutations among HER2+ tumour progression. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5168por Fasching, Peter A, Delea, Thomas E, Lu, Yen-Shen, De Boer, Richard, Hurvitz, Sara A, Moynahan, Aaron, Chandiwana, David, Lanoue, Brad, Hu, Huilin, Thuerigen, Astrid, O’Shaughnessy, Joyce“…PURPOSE: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) plus endocrine therapy are recommended for first-line treatment of hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) advanced breast cancer (ABC). However, not all CDK4/6i trials have reported significant overall survival (OS) benefit, and there have been no head-to-head trials. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5169
-
5170por Shidahara, Tomohiro, Ohsumi, Shozo, Miyoshi, Yuichiro, Takahashi, Mina, Takashima, Seiki, Aogi, Kenjiro, Teramoto, Norihiro“…Chemotherapy is often difficult to treat human epidermal growth factor receptor 2 (HER2)-positive metastatic recurrent breast cancer in the elderly, and no standard treatment has been established at this point. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5171“…SIMPLE SUMMARY: In the treatment of hormone-receptor positive, HER2 negative metastatic breast cancer, targeted therapy showed improved overall survival and it has become an established treatment within recent years. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5172por Ginzac, Angeline, Bernadach, Maureen, Molnar, Ioana, Duclos, Martine, Thivat, Emilie, Durando, Xavier“…BACKGROUND: The standard care for HER2-positive breast cancer is chemotherapy plus a HER2-directed therapy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5173por Shang, Mao, Chi, Yajing, Zhang, Jianbo, Chang, Jin, Yang, Hui, Yin, Sha, Tan, Qiaorui, Man, Xiaochu, Li, Huihui“…INTRODUCTION: Neoadjuvant trastuzumab plus chemotherapy may affect programmed death-ligand 1 (PD-L1) expression and tumor-infiltrating lymphocytes (TILs) in HER2-positive breast cancer. Discordant results were shown on the correlation between PD-L1 expression or TILs and the effectiveness of neoadjuvant therapy in HER2-positive breast cancer patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5174por Wang, Li, Li, Xiaomo, Cheng, Yurong, Yang, Jing, Liu, Si, Ma, Tonghui, Luo, Li, Hu, Yanping, Cai, Yi, Yan, Dong“…HER2 amplification/overexpression is a common driver in a variety of cancers including gallbladder cancer (GBC). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5175por Park, Joo-Hwan, Yeo, Ja Hyun, Kim, Young Saing, Park, Inkeun, Ahn, Hee Kyung, Cho, Eun Kyung, Shin, Dong Bok, Yang, Jun-Young, Kim, Hyung-Sik, Lee, Woon Kee, Sym, Sun Jin“…OBJECTIVES: Treatment with trastuzumab and chemotherapy significantly improves the outcome in patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (AGC). CT-P6 (trastuzumab-pkrb; Herzuma) is a trastuzumab biosimilar approved for the treatment of HER2-positive gastric cancer. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5176por Murayama, Masanori A., Takada, Erika, Takai, Kenji, Arimitsu, Nagisa, Shimizu, Jun, Suzuki, Tomoko, Suzuki, Noboru“…Microarray expression profiling identified several molecular subtypes, namely luminal-type (with a good-prognosis), HER2-type (with an intermediate-prognosis), and triple-negative breast cancer (TNBC)-type (with a poor-prognosis). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5177“…We aimed to develop a nomogram to predict the probability of achieving pCR in estrogen receptor-positive (ER+), HER2-negative (HER2−) breast cancer patients. METHODS: A total of 273 ER+, HER2− breast cancer patients who received 4 cycles of thrice-weekly standard NACT in the First Affiliated Hospital of Chongqing Medical University were retrospectively enrolled. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5178por Tehrani, Sadra Samavarchi, Zaboli, Ehsan, Sadeghi, Farzin, Khafri, Soraya, Karimian, Ansar, Rafie, Mahnoosh, Parsian, Hadi“…Hence, we aimed to investigate the effect of trastuzumab on the expression levels of microRNA-26a in HER-2 positive BC patients. METHODS: This study was conducted among HER-2 + and HER-2 Negative (−) BC patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5179por Le, Xiuning, Cornelissen, Robin, Garassino, Marina, Clarke, Jeffrey M., Tchekmedyian, Nishan, Goldman, Jonathan W., Leu, Szu-Yun, Bhat, Gajanan, Lebel, Francois, Heymach, John V., Socinski, Mark A.“…Insertion mutations in Erb-b2 receptor tyrosine kinase 2 gene (ERBB2 or HER2) exon 20 occur in 2%-5% of non–small-cell lung cancers (NSCLCs) and function as an oncogenic driver. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5180por Palleschi, Michela, Prochowski Iamurri, Andrea, Scarpi, Emanuela, Mariotti, Marita, Maltoni, Roberta, Mannozzi, Francesca, Barone, Domenico, Paganelli, Giovanni, Casi, Michela, Giampalma, Emanuela, De Giorgi, Ugo, Rocca, Andrea“…However, their prognostic value in patients with HER2-positive metastatic breast cancer (BC) receiving first line treatment with dual anti-HER2 antibody blockade is unknown. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto